These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27665541)

  • 1. Degradation of two novel congenital TTP ADAMTS13 mutants by the cell proteasome prevents ADAMTS13 secretion.
    Underwood M; Peyvandi F; Garagiola I; Machin S; Mackie I
    Thromb Res; 2016 Nov; 147():16-23. PubMed ID: 27665541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel ADAMTS13-p.D187H mutation impairs ADAMTS13 activity and secretion and contributes to thrombotic thrombocytopenic purpura in mice.
    De Cock E; Hermans C; De Raeymaecker J; De Ceunynck K; De Maeyer B; Vandeputte N; Vandenbulcke A; Deckmyn H; Rottensteiner H; De Maeyer M; De Meyer SF; Vanhoorelbeke K
    J Thromb Haemost; 2015 Feb; 13(2):283-92. PubMed ID: 25442981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro and in-vivo consequences of mutations in the von Willebrand factor cleaving protease ADAMTS13 in thrombotic thrombocytopenic purpura.
    Donadelli R; Banterla F; Galbusera M; Capoferri C; Bucchioni S; Gastoldi S; Nosari S; Monteferrante G; Ruggeri ZM; Bresin E; Scheiflinger F; Rossi E; Martinez C; Coppo R; Remuzzi G; Noris M;
    Thromb Haemost; 2006 Oct; 96(4):454-64. PubMed ID: 17003922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
    Schiphorst RH; van de Kar NC; van den Heuvel LP
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Prevention of Congenital Thrombotic Thrombocytopenic Purpura in ADAMTS13 Knockout Mice by Sleeping Beauty Transposon-Mediated Gene Therapy.
    Verhenne S; Vandeputte N; Pareyn I; Izsvák Z; Rottensteiner H; Deckmyn H; De Meyer SF; Vanhoorelbeke K
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):836-844. PubMed ID: 28254814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel homozygous frameshift mutation in Exon 7 of the ADAMTS13 gene in a patient with congenital thrombotic thrombocytopenic purpura from India: a case report.
    Yadav S; Shetty S; Kulkarni B
    Transfusion; 2017 Nov; 57(11):2712-2714. PubMed ID: 28833243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Siblings with congenital thrombotic thrombocytopenic purpura].
    Funakoshi Y; Okada M; Matsumoto M; Kokame K; Moriuchi H
    Rinsho Ketsueki; 2017; 58(8):933-937. PubMed ID: 28883277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura.
    Manea M; Kristoffersson A; Schneppenheim R; Saleem MA; Mathieson PW; Mörgelin M; Björk P; Holmberg L; Karpman D
    Br J Haematol; 2007 Sep; 138(5):651-62. PubMed ID: 17627784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of four ADAMTS13 mutations responsible for congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).
    Hommais A; Rayes J; Houllier A; Obert B; Legendre P; Veyradier A; Girma JP; Ribba AS
    Thromb Haemost; 2007 Sep; 98(3):593-9. PubMed ID: 17849048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and Functional Characterization of ADAMTS13 Variants in a Patient Cohort with Upshaw-Schulman Syndrome Investigated in Germany.
    Hassenpflug WA; Obser T; Bode J; Oyen F; Budde U; Schneppenheim S; Schneppenheim R; Brehm MA
    Thromb Haemost; 2018 Apr; 118(4):709-722. PubMed ID: 29554699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura.
    Lotta LA; Garagiola I; Palla R; Cairo A; Peyvandi F
    Hum Mutat; 2010 Jan; 31(1):11-9. PubMed ID: 19847791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura.
    Manea M; Kristoffersson A; Tsai HM; Zhou W; Winqvist I; Oldaeus G; Billström R; Björk P; Holmberg L; Karpman D
    Eur J Pediatr; 2007 Mar; 166(3):249-57. PubMed ID: 17187257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAMTS13 Secretion and Residual Activity among Patients with Congenital Thrombotic Thrombocytopenic Purpura with and without Renal Impairment.
    Rurali E; Banterla F; Donadelli R; Bresin E; Galbusera M; Gastoldi S; Peyvandi F; Underwood M; Remuzzi G; Noris M
    Clin J Am Soc Nephrol; 2015 Nov; 10(11):2002-12. PubMed ID: 26342041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
    Kato S; Fujimura Y
    Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phenotype-genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom.
    Camilleri RS; Scully M; Thomas M; Mackie IJ; Liesner R; Chen WJ; Manns K; Machin SJ
    J Thromb Haemost; 2012 Sep; 10(9):1792-801. PubMed ID: 22783805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low incidence of ADAMTS13 missense mutation R1060W in adult Egyptian patients with thrombotic thrombocytopenic purpura.
    El Sissy MH; El Hafez AA; El Sissy AH
    Acta Haematol; 2014; 132(1):30-5. PubMed ID: 24401653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutations in ADAMTS13 CUB domains cause abnormal pre-mRNA splicing and defective secretion of ADAMTS13.
    Jiang Y; Huang D; Kondo Y; Jiang M; Ma Z; Zhou L; Su J; Bai X; Ruan C; Wang Z; Xia L
    J Cell Mol Med; 2020 Apr; 24(7):4356-4361. PubMed ID: 32073234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency.
    Assink K; Schiphorst R; Allford S; Karpman D; Etzioni A; Brichard B; van de Kar N; Monnens L; van den Heuvel L
    Kidney Int; 2003 Jun; 63(6):1995-9. PubMed ID: 12753286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital thrombotic thrombocytopenic purpura caused by new compound heterozygous mutations of the ADAMTS13 gene.
    Rank CU; Kremer Hovinga J; Taleghani MM; Lämmle B; Gøtze JP; Nielsen OJ
    Eur J Haematol; 2014 Feb; 92(2):168-71. PubMed ID: 24033710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond.
    Lian EC
    Semin Thromb Hemost; 2005 Dec; 31(6):625-32. PubMed ID: 16388413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.